Nixing bone cancer fuel supply offers new treatment approach, mouse study suggests (IMAGE)
Caption
A new study from Washington University School of Medicine in St. Louis suggests that a two-drug combination targeting a tumor's energy sources could be as effective and less toxic than methotrexate, a long-used chemotherapy drug often given in high doses to treat osteosarcoma, a bone cancer. Shown is a cross section of osteosarcoma.
Credit
RICHA RATHORE
Usage Restrictions
None
License
Licensed content